Virological Outcomes of EVG/COBI/FTC/TDF and EVG/COBI/FTC/TAF in Antiretroviral-Naive HIV-1-Infected Participants with Baseline HIV-1 RNA =1,000,000 Copies/ml: A Post Hoc Analysis of Phase III Clinical Trials

Autor: Sax, Paul, DeJesus, Edwin, Wohl, David, DeMorin, Jennifer, McColl, Damian, Piontkowsky, David, Cohen, Calvin, Wang, Hui, White, Kirsten, Callebaut, Christian, Rhee, Martin, Das, Moupali, Quirk, Erin

Publikováno v: Antiviral Therapy; January 2018, Vol. 23 Issue: 1 p95-99, 5p

Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate in Asian Subjects with Human Immunodeficiency Virus 1 Infection: A Sub-Analysis of Phase 3 Clinical Trials.

Autor: Jun Yong Choi, Sungkanuparph, Somnuek, Anekthananon, Thanomsak, Sax, Paul, Dejesus, Edwin, Edelstein, Howard, Nelson, Mark, Demorin, Jennifer, Liu, Hui C., Swamy, Raji, Joonwoo Bahn, Sunjin Hwang, Sang Youn Yang, Ng, Christopher, Piontkowsky, David

Publikováno v: Infection & Chemotherapy; Sep2016, Vol. 48 Issue 3, p219-224, 6p

Long-term efficacy and safety of E/C/F/TDF vs EFV/FTC/TDF and ATV+RTV+FTC/TDF in HIV-1-infected treatment-naïve subjects ≥50 years.

Autor: Gazzard, Brian, Marie Girard, Pierre, Di Perri, Giovanni, Gallant, Joel, Towner, William, Rogatto, Felipe, Demorin, Jennifer, McColl, Damian, Liu, Hui, Rhee, Martin, Szwarcberg, Javier, Piontkowsky, David

Publikováno v: Journal of the International AIDS Society; Nov2014 Supplement 4S3, Vol. 17, pn/a-n/a, 2p, 1 Chart

Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate in Asian Subjects with Human Immunodeficiency Virus 1 Infection: A Sub-Analysis of Phase 3 Clinical Trials.

Autor: Choi JY; Department of Internal Medicine, Severance Hospital, Yonsei University, College of Medicine, Seoul, Korea. seran@yuhs.ac., Sungkanuparph S; Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand., Anekthananon T; Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand., Sax P; Brigham and Women's Hospital. Boston, MA, USA., DeJesus E; Orlando Immunology Center, Orlando, FL, USA., Edelstein H; Highland General Hospital, Oakland, CA, USA., Nelson M; Chelsea and Westminster Hospital, London, UK., DeMorin J; Gilead Sciences, Inc Foster City, CA, USA., Liu HC; Gilead Sciences, Inc Foster City, CA, USA., Swamy R; Gilead Sciences, Inc Foster City, CA, USA., Bahn J; Gilead Sciences Korea Ltd, Seoul, Korea., Hwang S; Gilead Sciences Korea Ltd, Seoul, Korea., Yang SY; Gilead Sciences Korea Ltd, Seoul, Korea., Ng C; Gilead Sciences, Inc Foster City, CA, USA., Piontkowsky D; Gilead Sciences, Inc Foster City, CA, USA.

Publikováno v: Infection & chemotherapy [Infect Chemother] 2016 Sep; Vol. 48 (3), pp. 219-224.